Suppr超能文献

儿童期对β-内酰胺类抗生素的过敏反应:六年调查

Anaphylaxis to beta-lactam antibiotics at pediatric age: Six-year survey.

作者信息

Azevedo J, Gaspar Â, Mota I, Benito-Garcia F, Alves-Correia M, Chambel M, Morais-Almeida M

机构信息

Immunoallergy Department, Coimbra Hospital Universitary Centre, Coimbra, Portugal.

Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal.

出版信息

Allergol Immunopathol (Madr). 2019 Mar-Apr;47(2):128-132. doi: 10.1016/j.aller.2018.07.008. Epub 2018 Sep 21.

Abstract

INTRODUCTION

Beta-lactams are the most frequently used antibiotics in pediatric age. Anaphylactic reactions may occur and need to be properly studied, but studies in children are scarce.

OBJECTIVE

Characterization of case reports of anaphylaxis in children referred to an allergy department with suspected beta-lactams hypersensitivity.

MATERIALS AND METHODS

Retrospective analysis of all children referred to our Drug Allergy Center with suspected beta-lactams hypersensitivity between January 2011 and December 2016. Description of the drug allergy work-up performed studied according to standardized diagnostic procedures of ENDA/EAACI, including specific-IgE assay, skin prick and intradermal tests and diagnostic/alternative drug challenge tests.

RESULTS

146 children with suspected beta-lactams hypersensitivity were studied, and in 21 (14.4%) the diagnosis was confirmed. In all of them, except for three children, an alternative beta-lactam was found. In seven children (33.3% of those with confirmed beta-lactams hypersensitivity) anaphylaxis was confirmed, and all of them described reactions with cutaneous and respiratory or gastrointestinal involvement. The culprit drug was amoxicillin in six and flucloxacillin in one. In this sample, we also performed oral challenge with cefuroxime, being negative in all cases. Almost all cases of confirmed anaphylaxis (six from seven cases) were IgE mediated, with positive skin tests despite negative serum specific-IgE.

CONCLUSIONS

Allergic reactions to beta-lactams, although rare in children, require a detailed clinical history and a specialized drug allergy work-up to allow a correct diagnosis as well as to avoid the possibility of a potential life-threatening reaction and provide alternative drugs.

摘要

引言

β-内酰胺类药物是儿科最常用的抗生素。可能会发生过敏反应,需要进行适当研究,但针对儿童的研究较少。

目的

对转诊至过敏科怀疑β-内酰胺类药物过敏的儿童过敏反应病例报告进行特征分析。

材料与方法

回顾性分析2011年1月至2016年12月间转诊至我们药物过敏中心怀疑β-内酰胺类药物过敏的所有儿童。根据欧洲过敏与临床免疫学会(ENDA/EAACI)的标准化诊断程序描述所进行的药物过敏检查,包括特异性IgE检测、皮肤点刺试验和皮内试验以及诊断性/替代性药物激发试验。

结果

研究了146例怀疑β-内酰胺类药物过敏的儿童,其中21例(14.4%)确诊。除3名儿童外,所有确诊儿童均发现了替代β-内酰胺类药物。7名儿童(确诊β-内酰胺类药物过敏儿童中的33.3%)确诊为过敏反应,所有患儿均描述有皮肤、呼吸或胃肠道受累的反应。罪魁祸首药物6例为阿莫西林,1例为氟氯西林。在该样本中,我们还对头孢呋辛进行了口服激发试验,所有病例结果均为阴性。几乎所有确诊过敏反应的病例(7例中的6例)均为IgE介导,尽管血清特异性IgE阴性,但皮肤试验呈阳性。

结论

β-内酰胺类药物过敏反应在儿童中虽罕见,但需要详细的临床病史和专业的药物过敏检查,以便做出正确诊断,同时避免潜在的危及生命的反应,并提供替代药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验